Anissa Chan, Ph.D., is a motivated scientist with over 20 years of experience in the biotechnology sector. Before joining HiberCell, Anissa was a principal scientist at Biothera Pharmaceuticals, Inc. She has extensive experience in evaluation of immunpharmacodynamic markers in human whole blood samples associated with Phase I/II/III healthy volunteer and cancer patient trials.
She credits her foundational industry training as a scientist at Bio-Techne (previously known as R&D Systems), where she was the project lead for stem cell product development and also oversaw the scaleup manufacture process of stem cell products. She also supported expansion of application of antibody and cytokines in immunological research. She has authored several peer-reviewed manuscripts and patents.
She received her B.S. from National Cheng Kung University, Taiwan and Ph.D in microbiology and immunology from University of Michigan, Ann Arbor.